... Food and Drug Administration (FDA) has approved insulin aspart-szjj (Merilog), the first rapid-acting insulin biosimilar. Like insulin aspart (NovoLog) — the product it’s based on — Merilog helps manage blood sugar spikes around mealtime for people living with diabetes. ...